Sudden Cardiac Death Risk Stratification in Patients with Heart Failure

Heart Failure Clinics

Volumn 7, Issue 2, 2011, Pages 157-174

  Lorvidhaya, Peem ^a   Addo, Kamel ^a   Chodosh, Adam ^a   Iyer, Venkat ^a   Lum, Jeremy ^a   Buxton, Alfred E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Heart failure; Risk stratification; Sudden cardiac death; Ventricular premature depolarization

Indexed keywords

(3 IODOBENZYL)GUANIDINE;

ARRHYTHMOGENESIS; DEFIBRILLATOR; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY MONITORING; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MICROVOLT T WAVE ALTERNANS TESTING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSORECEPTOR REFLEX; PROGNOSIS; QT PROLONGATION; REENTRY TACHYCARDIA; REVIEW; RISK ASSESSMENT; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SUPRAVENTRICULAR PREMATURE BEAT; T WAVE;

ADRENERGIC BETA-ANTAGONISTS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VENTRICULAR PREMATURE COMPLEXES;

EID: 79952843556     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.12.001     Document Type: Review

References (126)

1. Rouleau J.L., Talajic M., Sussex B., et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: The Canadian Assessment of Myocardial Infarction (CAMI) study. J Am Coll Cardiol 1996, 27:1119-1127.
2. Lee D.S., Gona P., Vasan R.S., et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 2009, 119:3070-3077.
3. Tribouilloy C., Rusinaru D., Mahjoub H., et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008, 29:339-347.
4. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the CC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices). J Am Coll Cardiol 2008, 51:2085-2105.
5. Gorgels A.P.M., Gijsbers C., de Vreede-Swagemakers J., et al. Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 2003, 24:1204-1209.
6. Stecker E.C., Vickers C., Waltz J., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction. Two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006, 47:1161-1166.
7. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999, 353:2001-2007.
8. Buxton A.E., Hafley G.E., Lee K.L., MUSTT Investigators, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease. Circulation 2002, 106:2466-2472.
9. Yap Y.G., Duong T., Bland M., et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 2005, 26:1385-1393.
10. Ross A.M., Coyne K.S., Moreyra E., et al. Extended mortality benefit of early postinfarction reperfusion. Circulation 1998, 97:1549-1556.
11. Goldenberg I., Vyas A.K., Hall W.J., Madit II Investigators, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008, 51:288-296.
12. Vogel-Claussen J., Rochitte C., Wu K., et al. Delayed enhancement MR imaging: Utility in myocardial assessment. Radiographics 2006, 26:795-810.
13. Wu T.J., Ong J.J., Hwang C., et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 1998, 32:187-196.
14. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005, 45:1104-1108.
15. Hsia H.H., Lin D., Sauer W.H., et al. Anatomic characterization of endocardial substrate for hemodynamically stable reentrant ventricular tachycardia: identification of endocardial conducting channels. Heart Rhythm 2006, 3:503-512.
16. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006-2014.
17. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32-39.
18. Wu K., Weiss R., Thiemann D., et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008, 51:2414-2421.
19. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiac magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977-1985.
20. Nazarian S., Bluemke D.A., Lardo A.C., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005, 112:2821-2825.
21. Baumgart D., Haude M., Gorge G., et al. Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999, 99:2090-2097.
22. Cohn J., Levine T., Olivari M., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984, 311:819-823.
23. Floras J. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993, 22:72-84.
24. Packer M. The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992, 20:248-254.
25. Bristow M., Anderson F., Port J., et al. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991, 84:1024-1039.
26. Bristow M.R., Minobe W., Rasmussen R., et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 1992, 89:803-815.
27. Ungerer M., Bohm M., Elce J., et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 1993, 87:454-463.
28. Schwartz P., Billman G., Stone H. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 1984, 69:790-800.
29. La Rovere M., Pinna G., Hohnloser S., et al. The Autonomic Tone and Relfexes After Myocardial Infarction (ATRAMI) Investigators. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation 2001, 103:2072-2077.
30. La Rovere M.T., Pinna G.D., Maestri R., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003, 107:565-570.
31. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk trial (UK-HEART). Circulation 1998, 98:1510-1516.
32. Eckberg D.L., Sleight P. Human baroreflexes in health and disease 1992, Clarendon Press, Oxford (UK).
33. Pinna G., LaRovere M., Maestri R., et al. Comparison between invasive and non-invasive measurements of baroreflex sensitivity. Implications for studies on risk stratification after a myocardial infarction. Eur Heart J 2000, 21:1522-1529.
34. Farrell T.G., Odemuyiwa O., Bashir Y., et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 1992, 67:129-137.
35. La Rovere M.T., Specchia G., Mortara A., et al. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 1988, 78:816-824.
36. Schwartz P.J., La Rovere M.T., Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992, 85:I77-I91.
37. La Rovere M., Bigger J.T., Marcus F., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998, 351:478-484.
38. Exner D.V., Kavanagh K.M., Slawnych M.P., REFINE Investigators, et al. Noninvasive risk assessment early after a myocardial infarction: the REFINE study. J Am Coll Cardiol 2007, 50:2275-2284.
39. Mortara A., La Rovere M.T., Pinna G.D., et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 1997, 96:3450-3458.
40. Osterziel K., Hanlein D., Willenbrock R., et al. Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 1995, 73:517-522.
41. La Rovere M., Pinna G., Maestri R., et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 2009, 53:193-199.
42. Schmidt G., Malik M., Barthel P., et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999, 353:1390-1396.
43. Barthel P., Schneider R., Bauer A., et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003, 108:1221-1226.
44. Bauer A., Barthel P., Muller A., et al. Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. J Electrocardiol 2009, 42:597-601.
45. Ghuran A., Reid F., La Rovere M.T., et al. on behalf of the ATRAMI investigators. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction Substudy). Am J Cardiol 2002, 89:184-190.
46. Zhong J-H., Chen X-P., Zeng C-F., et al. Effect of benazepril on heart rate turbulence in patients with dilated cardiomyopathy. Clin Exp Pharmacol 2007, 34:612-616.
47. Moore R.K., Groves D.G., Barlow P.E., et al. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail 2006, 8:585-590.
48. Cygankiewicz I., Zareba W., Vazquez R., et al. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm 2008, 5:1095-1102.
49. Stein P.K., Deedwania P. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study). Amer J Cardiol 2009, 103:1495-1499.
50. Chiang B., Perlman L., Ostrander L., et al. Relationship of premature systoles to coronary heart disease and sudden death in the Techumseh epidemiologic study. Ann Intern Med 1969, 70:1159-1166.
51. Hiss R., Lamb L. Electrocardiographic findings in 122,043 individuals. Circulation 1962, 25:947-961.
52. Brodsky M., Wu D., Denes P., et al. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977, 39:390-395.
53. Sobotka P.A., Mayer J.H., Bauernfeind R.A., et al. Arrhythmias documented by 24-hour continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease. Am Heart J 1981, 101:753-759.
54. Suyama A., Anan T., Araki H., et al. Prevalence of ventricular tachycardia in patients with different underlying heart diseases: a study by Holter ECG monitoring. Am Heart J 1986, 112:44-51.
55. Neri R., Mestroni L., Salvi A., et al. Arrhythmias in dilated cardiomyopathy. Postgrad Med J 1986, 62:593-597.
56. Meinertz T., Hofmann T., Kasper W., et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984, 53:902-907.
57. Huang S.K., Messer J.V., Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 1983, 51:507-512.
58. Olshausen K.V., Stienen U., Schwarz F., et al. Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1988, 61:146-151.
59. Doval H.C., Nul D.R., Grancelli H.O., et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation 1996, 94:3198-3203.
60. Singh S.N., Fisher S.G., Carson P.E., et al. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol 1998, 32:942-947.
61. Roden D.M., Lazzara R., Rosen M., et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS foundation task force on LQTS. Circulation 1996, 94:1996-2012.
62. el-Sherif N., Turitto G. The long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol 1999, 22:91-110.
63. Buxton A.E., Waxman H.L., Marchlinski F.E., et al. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1983, 68:917-927.
64. Lerman B.B., Stein K., Engelstein E.D., et al. Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 1995, 92:421-429.
65. Pogwizd S.M. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation 1995, 92:1034-1048.
66. Pogwizd S.M. Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation 1994, 90:1441-1458.
67. Holmes J., Kubo S.H., Cody R.J., et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985, 55:146-151.
68. Gradman A., Deedwania P., Cody R., et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 1989, 14:564-570. [discussion: 571-2].
69. Wilson J.R., Schwartz J.S., Sutton M.S., et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983, 2:403-410.
70. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350:2151-2158.
71. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
72. Pantano J.A., Oriel R.J. Prevalence and nature of cardiac arrhythmias in apparently normal well-trained runners. Am Heart J 1982, 104:762-768.
73. Teerlink J.R., Jalaluddin M., Anderson S., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 2000, 101:40-46.
74. Thanavaro S., Kleiger R.E., Miller J.P., et al. Coupling interval and types of ventricular ectopic activity associated with ventricular runs. Am Heart J 1983, 106:484-491.
75. Unverferth D.V., Magorien R.D., Moeschberger M.L., et al. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984, 54:147-152.
76. Zecchin M., Di Lenarda A., Gregori D., et al. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?. Pacing Clin Electrophysiol 2008, 31:290-299.
77. Berbari E.J. High resolution electrocardiography. Cardiac electrophysiology: from cell to bedside 2009, 793-802. Saunders, Philadelphia. D.P. Zipes, J. Jalife (Eds.).
78. Berbari E., Scherlan R., Hope R., et al. Recordings from body surface of arrhythmogenic ventricular activity during the ST segment. Am J Cardiol 1978, 41:697-702.
79. Cain M.E., Anderson J.L., Arnsdorf M.F., et al. ACC expert consensus document: Signal-averaged electrocardiography. J Am Coll Cardiol 1996, 27:238-249.
80. Simpson M. Use of signals in the terminal QRS complex to identify patients with recurrent ventricular tachycardia after myocardial infarction. Circulation 1981, 64:235-242.
81. Breithardt G., Becker R., Seipel L., et al. Non-invasive detection of late potentials in man: a new marker for ventricular tachycardia. Eur Heart J 1981, 2:1-11.
82. El-Sherif N., Denes P., Katz R., et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995, 25:908-914.
83. Gomes J., Mehra R., Barreca P., et al. Quantitative analysis of the high frequency components of the signal-averaged QRS complex in acute myocardial infarction. Circulation 1985, 72:105-111.
84. Gomes J., Winters S., Martinson M., et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol 1988, 13:377-384.
85. Gomes J.A., Winters S., Stewart D., et al. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-average electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 1987, 10:349-357.
86. Kuchar D.L., Thorburn C.W., Sammel N.L. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol 1987, 9:531-538.
87. Mancini D., Wong K., Simson M. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993, 87:1083-1092.
88. Middlekauff H., Stevenson W., Woo M., et al. Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol 1990, 66:1113-1117.
89. Silverman M., Pressel M., Brackett J., et al. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 1995, 75:460-464.
90. Gomes J., Cain M., Buxton A., et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001, 104:436-441.
91. Brembilla-Perrot B., Donetti J., de la Chaise A.T., et al. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991, 121:1124-1131.
92. Grimm W., Hoffmann J., Menz V., et al. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 1998, 32:739-745.
93. Becker R., Haass M., Ick D., et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 2003, 98:259-266.
94. Rolf S., Haverkamp W., Borggrefe M., et al. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis. Europace 2009, 11:289-296.
95. Andresen D., Steinbeck G., Bruggemann T., et al. Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods. J Am Coll Cardiol 1999, 33:131-138.
96. Bhandari A.K., Rose J.S., Kotlewski A., et al. Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarction. Am J Cardiol 1985, 56:737-742.
97. Bourke J.P., Richards D.A., Ross D.L., et al. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol 1991, 18:780-788.
98. Richards D.A., Byth K., Ross D.L., et al. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?. Circulation 1991, 83:756-763.
99. Brembilla-Perrot B., de la Chaise A.T., Briancon S., et al. Programmed ventricular stimulation in survivors of acute myocardial infarction: long-term follow-up. Int J Cardiol 1995, 49:55-65.
100. Zaman S., Sivagangabalan G., Narayan A., et al. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation 2009, 120:194-200.
101. Raviele A., Bongiorni M.G., Brignole M., BEST+ICD Trial Investigators, et al. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The Beta-Blocker Strategy plus ICD trial. Europace 2005, 7:327-337.
102. Buxton A.E., Marchlinski F.E., Flores B.T., et al. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Circulation 1987, 75:1178-1185.
103. Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000, 342:1937-1945.
104. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999, 341:1882-1890.
105. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1933-1940.
106. Costantini O., Hohnloser S.H., Kirk M.M., ABCD Trial Investigators, et al. The ABCD (alternans before cardioverter defibrillator) trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol 2009, 53:471-479.
107. Kashani A., Barold S.S. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005, 46:2183-2192.
108. Zimetbaum P.J., Buxton A.E., Batsford W., et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation 2004, 110:766-769.
109. Freedman R.A., Alderman E.L., Sheffield L.T., et al. Bundle branch block in patients with chronic coronary artery disease: angiographic correlates and prognostic significance. J Am Coll Cardiol 1987, 10:73-80.
110. Siscovick D.S., Raghunathan T.E., Rautaharju P., et al. Clinically silent electrocardiographic abnormalities and risk of primary cardiac arrest among hypertensive patients. Circulation 1996, 94:1329-1333.
111. Almendral J., Villacastin J., Arenal A., et al. Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. Am J Cardiol 1995, 76:60D-63D.
112. Brooksby P., Batin P.D., Nolan J., et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-heart). Eur Heart J 1999, 20:1335.
113. Padmanabhan S., Silvet H., Amin J., et al. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic function: Results from a cohort of 2265 patients with an ejection fraction of ≤ 40%. Am Heart J 2003, 145:132-138.
114. Brendorp B., Elming H., Jun L., et al. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 2001, 103:831-835.
115. Fei L., Goldman J., Prasad K., et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996, 17:258-263.
116. Galinier M., Vialette J.C., Fourcade J., et al. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure: importance of aetiology. Eur Heart J 1998, 19:1054-1062.
117. Pinsky D., Sciacca R., Steinberg J. QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 1997, 29:1576-1584.
118. Berger R.D., Kasper E.K., Baughman K.L., et al. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997, 96:1557-1565.
119. Haigney M.C., Zareba W., Gentlesk P.J., et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol 2004, 44:1481-1487.
120. Gehi A.K., Stein R.H., Metz L.D., et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 2005, 46:75-82.
121. Gold M.R., Ensley D., Chilson D., et al. T-wave alternans SCD HeFT study: primary endpoint analysis. Circulation 2007, 114:428.
122. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA study. J Am Coll Cardiol 2007, 50:1896-1904.
123. Chow T., Kereiakes D.J., Onufer J., et al. on behalf of the MASTER Trial Investigators. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators?: The MASTER (microvolt T wave alternans testing for risk stratification of post-myocardial infarction patients) trial. J Am Coll Cardiol 2008, 52:1607-1615.
124. Ikeda T., Yoshino H., Sugi K., et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort stud. J Am Coll Cardiol 2006, 48:2268-2274.
125. Pogwizd S.M., Bers D.M. Calcium cycling in heart failure: the arrhythmia connection. J Cardiovasc Electrophysiol 2002, 13:88-91.
126. Pogwizd S.M., Bers D.M. Na/Ca exchange in heart failure. Contractile dysfunction and arrhythmogenesis. Ann N Y Acad Sci 2002, 976:454-465.